Pablo Oppezzo

2.0k total citations
58 papers, 1.5k citations indexed

About

Pablo Oppezzo is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Pablo Oppezzo has authored 58 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Genetics, 28 papers in Molecular Biology and 26 papers in Immunology. Recurrent topics in Pablo Oppezzo's work include Chronic Lymphocytic Leukemia Research (36 papers), Immunodeficiency and Autoimmune Disorders (18 papers) and Lymphoma Diagnosis and Treatment (17 papers). Pablo Oppezzo is often cited by papers focused on Chronic Lymphocytic Leukemia Research (36 papers), Immunodeficiency and Autoimmune Disorders (18 papers) and Lymphoma Diagnosis and Treatment (17 papers). Pablo Oppezzo collaborates with scholars based in Uruguay, France and Argentina. Pablo Oppezzo's co-authors include Agustín Correa, Otto Pritsch, Guillaume Dighiero, Christian Magnac, Béatrice Payelle‐Brogard, Pedro M. Alzari, Gérard Dumas, Françoise Vuillier, Ana Inés Landoni and Eduardo Osinaga and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Pablo Oppezzo

58 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pablo Oppezzo Uruguay 22 700 637 603 410 235 58 1.5k
Sergio Roa United States 19 700 1.0× 601 0.9× 241 0.4× 322 0.8× 113 0.5× 35 1.3k
Carolyn Cheney United States 25 494 0.7× 864 1.4× 798 1.3× 615 1.5× 298 1.3× 59 1.9k
Alfred Lammens Germany 12 757 1.1× 708 1.1× 167 0.3× 278 0.7× 299 1.3× 17 1.5k
Marat Alimzhanov United States 18 656 0.9× 1.7k 2.7× 211 0.3× 246 0.6× 154 0.7× 41 2.4k
Sivasubramanian Baskar United States 23 730 1.0× 1.1k 1.8× 432 0.7× 241 0.6× 259 1.1× 58 2.0k
Niklas Feldhahn United States 21 1.2k 1.7× 642 1.0× 259 0.4× 158 0.4× 101 0.4× 41 2.1k
Frederick W. Alt United States 14 1.1k 1.6× 1.4k 2.2× 272 0.5× 111 0.3× 273 1.2× 17 2.4k
Sidorenko Sp Ukraine 19 743 1.1× 1.3k 2.0× 157 0.3× 83 0.2× 198 0.8× 45 2.0k
Shyr‐Jiann Li United States 6 1.4k 2.1× 220 0.3× 309 0.5× 194 0.5× 74 0.3× 7 1.8k
Pamela Hamlyn United Kingdom 15 931 1.3× 390 0.6× 215 0.4× 229 0.6× 393 1.7× 20 1.5k

Countries citing papers authored by Pablo Oppezzo

Since Specialization
Citations

This map shows the geographic impact of Pablo Oppezzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Oppezzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Oppezzo more than expected).

Fields of papers citing papers by Pablo Oppezzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Oppezzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Oppezzo. The network helps show where Pablo Oppezzo may publish in the future.

Co-authorship network of co-authors of Pablo Oppezzo

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Oppezzo. A scholar is included among the top collaborators of Pablo Oppezzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Oppezzo. Pablo Oppezzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mediavilla-Varela, Melanie, John J. Powers, Julio C. Chávez, et al.. (2025). Targeting S100A9-mediated inflammation: a novel therapeutic approach for CLL. Blood Advances. 9(20). 5219–5233. 1 indexed citations
2.
Sernbo, Sandra, Juan Pablo Tosar, Daniel Prieto, et al.. (2022). TGF-β/SMAD Pathway Is Modulated by miR-26b-5p: Another Piece in the Puzzle of Chronic Lymphocytic Leukemia Progression. Cancers. 14(7). 1676–1676. 9 indexed citations
3.
Morande, Pablo Elías, Xiao‐Jie Yan, Cecilia Abreu, et al.. (2021). AID overexpression leads to aggressive murine CLL and nonimmunoglobulin mutations that mirror human neoplasms. Blood. 138(3). 246–258. 8 indexed citations
4.
Berois, Nora, et al.. (2021). Docetaxel in chitosan-based nanocapsules conjugated with an anti-Tn antigen mouse/human chimeric antibody as a promising targeting strategy of lung tumors. International Journal of Biological Macromolecules. 182. 806–814. 21 indexed citations
5.
Colado, Ana, Enrique Podaza, María Belén Almejún, et al.. (2020). Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia. Cancer Immunology Immunotherapy. 69(5). 813–824. 6 indexed citations
6.
Morande, Pablo Elías, Mariela Sivina, Pablo Fresia, et al.. (2019). Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemia. Blood. 133(19). 2056–2068. 10 indexed citations
7.
Prieto, Daniel, Thaïs Souto-Padrón, Cecilia Guillermo, et al.. (2018). LPL protein in Chronic Lymphocytic Leukaemia have different origins in Mutated and Unmutated patients. Advances for a new prognostic marker in CLL. British Journal of Haematology. 182(4). 521–525. 11 indexed citations
8.
Morande, Pablo Elías, Mercedes Borge, Cecilia Abreu, et al.. (2014). Surface localization of high-mobility group nucleosome-binding protein 2 on leukemic B cells from patients with chronic lymphocytic leukemia is related to secondary autoimmune hemolytic anemia. Leukemia & lymphoma. 56(4). 1115–1122. 5 indexed citations
9.
Echeverría, Natalia, Gonzalo Moratorio, Ana Inés Landoni, et al.. (2014). Human endogenous retrovirus np9 gene is over expressed in chronic lymphocytic leukemia patients. Leukemia Research Reports. 3(2). 70–72. 28 indexed citations
10.
11.
Correa, Agustín & Pablo Oppezzo. (2014). Overcoming the Solubility Problem in E. coli: Available Approaches for Recombinant Protein Production. Methods in molecular biology. 1258. 27–44. 27 indexed citations
12.
Abreu, Cecilia, Pilar Moreno, Florencia Palacios, et al.. (2013). Methylation status regulates lipoprotein lipase expression in chronic lymphocytic leukemia. Leukemia & lymphoma. 54(8). 1844–1848. 14 indexed citations
13.
Correa, Agustín, Felipe Trajtenberg, Gonzalo Obal, et al.. (2013). Structure of a human IgA1 Fab fragment at 1.55 Å resolution: potential effect of the constant domains on antigen-affinity modulation. Acta Crystallographica Section D Biological Crystallography. 69(3). 388–397. 26 indexed citations
14.
Oppezzo, Pablo & G Dighiero. (2013). “Role of the B-cell receptor and the microenvironment in chronic lymphocytic leukemia’’. Blood Cancer Journal. 3(9). e149–e149. 31 indexed citations
15.
Hubert, Pascale, Sophie Viel, Nicolás André, et al.. (2011). Antibody-Dependent Cell Cytotoxicity Synapses Form in Mice during Tumor-Specific Antibody Immunotherapy. Cancer Research. 71(15). 5134–5143. 100 indexed citations
16.
Galletti, Jeremías G., Pablo Elías Morande, Mercedes Borge, et al.. (2008). Chronic Lymphocytic Leukemia Cells Bind and Present the Erythrocyte Protein Band 3: Possible Role as Initiators of Autoimmune Hemolytic Anemia. The Journal of Immunology. 181(5). 3674–3683. 24 indexed citations
17.
Oppezzo, Pablo. (2005). The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia. Blood. 106(2). 650–657. 109 indexed citations
18.
Vuillier, Françoise, Gérard Dumas, Christian Magnac, et al.. (2005). Lower levels of surface B-cell-receptor expression in chronic lymphocytic leukemia are associated with glycosylation and folding defects of the μ and CD79a chains. Blood. 105(7). 2933–2940. 51 indexed citations
19.
Oppezzo, Pablo, Gérard Dumas, Jean‐Pierre Bouvet, et al.. (2004). Somatic mutations can lead to a loss of superantigenic and polyreactive binding. European Journal of Immunology. 34(5). 1423–1432. 13 indexed citations
20.
Pritsch, Otto, Pablo Oppezzo, Renaud Du Pasquier, et al.. (1997). Molecular Cloning of a Monoclonal Anti-Tumor Antibody Specific for the Tn Antigen and Expression of an Active Single-Chain Fv Fragment. Hybridoma. 16(4). 317–324. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sergio Roa Breakdown of academic impact, for papers by Carolyn Cheney Breakdown of academic impact, for papers by Alfred Lammens Breakdown of academic impact, for papers by Marat Alimzhanov Breakdown of academic impact, for papers by Sivasubramanian Baskar Breakdown of academic impact, for papers by Niklas Feldhahn Breakdown of academic impact, for papers by Frederick W. Alt Breakdown of academic impact, for papers by Sidorenko Sp Breakdown of academic impact, for papers by Shyr‐Jiann Li Breakdown of academic impact, for papers by Pamela Hamlyn
Rankless by CCL
2026